Eliem Therapeutics, Inc.
ELYM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14 | -$35 | -$45 | -$47 |
| Dep. & Amort. | -$1 | $0 | $0 | $2 |
| Deferred Tax | $0 | $0 | -$1 | -$2 |
| Stock-Based Comp. | $6 | $13 | $7 | $4 |
| Change in WC | $0 | $4 | $0 | -$4 |
| Other Non-Cash | -$7 | -$2 | $2 | $12 |
| Operating Cash Flow | -$16 | -$21 | -$37 | -$36 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | -$5 | $0 | $0 | $0 |
| Inv. Purchases | -$132 | -$58 | -$88 | -$115 |
| Inv. Sales/Matur. | $21 | $127 | $122 | $0 |
| Other Inv. Act. | -$5 | $0 | $0 | -$0 |
| Investing Cash Flow | -$121 | $69 | $34 | -$115 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $120 | $1 | $0 | $83 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $131 | $1 | $0 | $94 |
| Financing Cash Flow | $131 | $1 | $0 | $177 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$6 | $50 | -$3 | $26 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $93 | $44 | $47 | $20 |
| End Cash | $87 | $93 | $44 | $47 |
| Free Cash Flow | -$16 | -$21 | -$37 | -$36 |